Literature DB >> 16862592

Comparison of protein active site structures for functional annotation of proteins and drug design.

Robert Powers1, Jennifer C Copeland, Katherine Germer, Kelly A Mercier, Viswanathan Ramanathan, Peter Revesz.   

Abstract

Rapid and accurate functional assignment of novel proteins is increasing in importance, given the completion of numerous genome sequencing projects and the vastly expanding list of unannotated proteins. Traditionally, global primary-sequence and structure comparisons have been used to determine putative function. These approaches, however, do not emphasize similarities in active site configurations that are fundamental to a protein's activity and highly conserved relative to the global and more variable structural features. The Comparison of Protein Active Site Structures (CPASS) database and software enable the comparison of experimentally identified ligand-binding sites to infer biological function and aid in drug discovery. The CPASS database comprises the ligand-defined active sites identified in the protein data bank, where the CPASS program compares these ligand-defined active sites to determine sequence and structural similarity without maintaining sequence connectivity. CPASS will compare any set of ligand-defined protein active sites, irrespective of the identity of the bound ligand. Proteins 2006. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862592     DOI: 10.1002/prot.21092

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  31 in total

1.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

2.  FAST-NMR: functional annotation screening technology using NMR spectroscopy.

Authors:  Kelly A Mercier; Michael Baran; Viswanathan Ramanathan; Peter Revesz; Rong Xiao; Gaetano T Montelione; Robert Powers
Journal:  J Am Chem Soc       Date:  2006-11-29       Impact factor: 15.419

Review 3.  Chemogenomic approaches to rational drug design.

Authors:  D Rognan
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

Review 4.  The application of FAST-NMR for the identification of novel drug discovery targets.

Authors:  Robert Powers; Kelly A Mercier; Jennifer C Copeland
Journal:  Drug Discov Today       Date:  2008-02       Impact factor: 7.851

5.  A survey of available tools and web servers for analysis of protein-protein interactions and interfaces.

Authors:  Nurcan Tuncbag; Gozde Kar; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Brief Bioinform       Date:  2009-02-24       Impact factor: 11.622

6.  Interaction force diagrams: new insight into ligand-receptor binding.

Authors:  Hooman Shadnia; James S Wright; James M Anderson
Journal:  J Comput Aided Mol Des       Date:  2008-11-07       Impact factor: 3.686

7.  Identification of low-molecular-weight compounds inhibiting growth of corynebacteria: potential lead compounds for antibiotics.

Authors:  Jaime L Stark; Jennifer C Copeland; Alexander Eletsky; Greg A Somerville; Thomas Szyperski; Robert Powers
Journal:  ChemMedChem       Date:  2014-01-08       Impact factor: 3.466

Review 8.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

9.  Statistical removal of background signals from high-throughput (1)H NMR line-broadening ligand-affinity screens.

Authors:  Bradley Worley; Nicholas J Sisco; Robert Powers
Journal:  J Biomol NMR       Date:  2015-07-09       Impact factor: 2.835

10.  Structural and functional similarity between the bacterial type III secretion system needle protein PrgI and the eukaryotic apoptosis Bcl-2 proteins.

Authors:  Matthew D Shortridge; Robert Powers
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.